Kalinina, A. A., Kazansky, D. B., & Khromykh, L. M. (2024). Anti-tumor effects of recombinant human cyclophilin A combined with immune checkpoint inhibitors in the experimental model of melanoma B16 in vivo. ABV-press.
Chicago Style (17th ed.) CitationKalinina, A. A., D. B. Kazansky, and L. M. Khromykh. Anti-tumor Effects of Recombinant Human Cyclophilin A Combined with Immune Checkpoint Inhibitors in the Experimental Model of Melanoma B16 in Vivo. ABV-press, 2024.
MLA (9th ed.) CitationKalinina, A. A., et al. Anti-tumor Effects of Recombinant Human Cyclophilin A Combined with Immune Checkpoint Inhibitors in the Experimental Model of Melanoma B16 in Vivo. ABV-press, 2024.
Warning: These citations may not always be 100% accurate.